SC
PAHC icon

SummitTX Capital’s Phibro Animal Health PAHC Stock Holding History

SummitTX Capital’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-75,466
Closed -$4.17M – 961
2026
Q1 		$4.17M Buy
75,466
+40,102
+113% +$1.91M 0.13% 185
2025
Q4 		$1.32M Buy
+35,364
New +$1.44M 0.04% 370

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SummitTX Capital's PAHC Position: Q2 2026 in Review

SummitTX Capital sold out of Phibro Animal Health (PAHC) in Q2 2026, closing a stake of 75,466 shares — an estimated $4.17M sold.

SummitTX Capital first reported a position in PAHC in Q4 2025 and held it in 2 quarters. The position peaked at $4.17M in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • SummitTX Capital reported no remaining Phibro Animal Health position as of Q2 2026 after selling out during the quarter.
  • SummitTX Capital sold 75,466 Phibro Animal Health shares in Q2 2026, an estimated $4.17M.
  • SummitTX Capital first reported a position in Phibro Animal Health in Q4 2025 and held it in 2 quarters.
  • SummitTX Capital's Phibro Animal Health position peaked at $4.17M in Q1 2026.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on SummitTX Capital's 13F filing for Q2 2026, filed 14 Aug 2026.